The first week brought nausea and strange dreams, but eating before the tablet helped. By the second week, cigarettes felt less rewarding, and I stopped on my planned date.
Champix
Champix is a prescription medicine containing varenicline for adults who want to stop smoking. It helps reduce nicotine cravings and withdrawal symptoms while making nicotine less rewarding.
Description
Champix is a prescription, non-nicotine smoking-cessation treatment containing varenicline. It is intended for adults who want to stop smoking, helping reduce nicotine cravings and withdrawal symptoms. Varenicline also reduces the rewarding effect of nicotine on the brain.
Composition
Champix contains varenicline and is supplied as film-coated tablets. The pack is marked CHAMPIX 1 mg, Varenicline, and 56 film-coated tablets; exact product details are stated on the pack and leaflet.
Dosage and usage
- Dose: The pack is marked CHAMPIX 1 mg; follow the dose prescribed by a healthcare professional.
- Frequency: Follow the prescribed number of tablets and times per day.
- Timing: Follow the leaflet or prescription for when to take the tablets in relation to meals and time of day.
- Duration: Follow the prescribed treatment duration.
- Route: Take the film-coated tablets orally with water, as directed in the leaflet or by a healthcare professional.
How it works
Varenicline acts at nicotine-related receptors in the brain. It helps reduce nicotine cravings and withdrawal symptoms while reducing the rewarding effect that nicotine normally produces. Champix is a non-nicotine treatment.
Indications
It is intended for adults who want to stop smoking, helping reduce nicotine cravings and withdrawal symptoms. Varenicline also reduces the rewarding effect of nicotine on the brain.
Comparison
Varenicline, bupropion, and nicotine replacement therapies act through different pathways. The best option depends on previous quit attempts, medical history, current medicines, kidney function, pregnancy status, and tolerance of adverse effects.
| Option | Main mechanism | Practical limitation |
|---|---|---|
| Champix, varenicline | Partial stimulation and blockade of α4β2 nicotinic receptors | Nausea, sleep disturbance, and dose adjustment in significant renal impairment |
| Bupropion | Modulates noradrenaline and dopamine pathways | Not suitable for people with seizure disorders or some eating disorders |
| Nicotine replacement therapy | Supplies nicotine through patches, gum, lozenges, or similar forms | Cravings may persist and correct combination use matters |
Clinical reviews have found varenicline more effective than NRT used alone for sustained smoking cessation, while combination NRT can narrow the difference. Bupropion can help some smokers, though its contraindications and interaction profile differ from varenicline [1].
E-cigarettes deliver nicotine through an aerosol rather than cigarette smoke. They are not pharmacologically identical to Champix, and they do not provide varenicline’s receptor-blocking effect. A person using vaping products alongside a quit attempt should define a clear nicotine-reduction plan rather than drifting between products indefinitely.
Contraindications
Champix is not suitable for a person with known hypersensitivity to varenicline or varenicline tartrate.
Varenicline is not routinely chosen during pregnancy because human safety data are limited.
When this is not for you
This medication is not for you if
- you have previously had an allergic reaction to varenicline;
- you have severe kidney impairment without an appropriate dose plan;
- you are pregnant and the expected benefit has not been weighed against possible risk;
- you are breastfeeding and a clinician has not assessed whether to continue breastfeeding or treatment;
- you develop severe swelling, breathing difficulty, or a serious skin reaction after a dose;
- you experience suicidal thoughts, severe agitation, psychosis, or a major change in behaviour.
People with a history of depression, bipolar disorder, psychosis, or suicidal behaviour need a clear monitoring plan. A psychiatric history does not automatically exclude treatment, but changes in mood, thinking, sleep, or behaviour should be reported quickly.
Older adults may require attention to kidney function because varenicline is cleared mainly through the kidneys. Severe renal impairment can increase exposure and may require a reduced dose.
The treatment decision should be specific to the patient’s circumstances rather than based on a general rule [3].
Side effects
Nausea is the most common adverse effect associated with Champix. It is often strongest during the first days or weeks and may improve when the medicine is taken after food with water.
Other reported effects include:
- vivid dreams or unusual dreams;
- insomnia or changes in sleep pattern;
- headache;
- dry mouth;
- constipation;
- indigestion;
- dizziness;
- fatigue.
Nicotine withdrawal can produce many of the same symptoms, including irritability, low mood, restlessness, difficulty concentrating, and disturbed sleep. A symptom appearing during a quit attempt may therefore reflect withdrawal, varenicline, or both.
Vivid dreams can be unsettling without being medically dangerous. Taking the evening dose earlier may help some people, although the prescribed twice-daily schedule should not be changed without a clinician’s direction.
Serious allergic reactions are uncommon but require urgent care. Warning signs include swelling of the face, mouth, tongue, lips, gums, throat, or extremities, along with breathing difficulty or widespread rash.
Mood or behaviour changes also need attention. Post-marketing reports have described depressed mood, agitation, unusual behaviour, suicidal thoughts, and other neuropsychiatric symptoms in people attempting to stop smoking. Smoking cessation itself can affect mood, so a sudden or severe change should be assessed promptly rather than attributed automatically to withdrawal.
The regulatory history of varenicline has included safety-label updates and additional evaluation of neuropsychiatric symptoms. The large EAGLES trial found no significant increase in serious neuropsychiatric adverse events attributable to varenicline compared with placebo or other cessation medicines in the studied groups, while monitoring remained clinically sensible [2].
Common mistakes
Several practical errors can make Champix seem less helpful than it is:
- starting at the full maintenance dose instead of using titration;
- taking tablets on an empty stomach despite repeated nausea;
- changing the dose after one uncomfortable night without medical advice;
- stopping treatment immediately after the first smoke-free week;
- continuing to keep cigarettes available in the home or car;
- ignoring new mood changes because they are assumed to be ordinary withdrawal;
- forgetting that smoking cessation can alter the effect of warfarin, theophylline, or insulin;
- doubling the next dose after a missed tablet;
- drinking heavily while trying to judge whether mood or behaviour has changed;
- treating one cigarette as proof that the entire quit attempt has failed.
What doctors say
In clinical practice, doctors often frame Champix as one part of a structured quit attempt. Varenicline can reduce the biological intensity of cravings, but it does not replace planning for stress, social pressure, habitual smoking times, or relapse after a lapse.
Prescribers usually look for three early markers: whether the titration is tolerated, whether cigarette consumption is falling, and whether the planned quit date is realistic. A lapse does not always mean treatment has failed. The patient should identify the trigger, remove remaining cigarettes, and return to the cessation plan.
A doctor will also ask about kidney disease, mental-health history, pregnancy or breastfeeding, alcohol use, and medicines affected by smoking cessation. These questions are practical risk assessment, not a judgement about the smoker.
The strongest results occur when medication is paired with behavioural support. WHO tobacco-cessation guidance supports combining pharmacological treatment with behavioural interventions because counselling, follow-up, and relapse planning improve the chance of sustained abstinence [4].
Frequently asked questions
How long does Champix take to work?
Varenicline begins acting during the first days of treatment, while the full maintenance dose is reached after titration. Dose escalation can affect early tolerability. Clinical follow-up helps distinguish expected effects from warning signs. FDA-reviewed evidence and the EAGLES trial published in 2016 found that varenicline reduced craving and withdrawal during smoking cessation. Some people notice fewer cigarettes feel rewarding before the planned quit date, while others need several weeks of consistent treatment.
Can Champix be taken with nicotine replacement therapy?
Varenicline and NRT have different mechanisms, so combined use requires a planned clinical approach. A 2016 Cochrane review found that combination cessation strategies can improve outcomes in selected smokers, although adverse effects such as nausea, dizziness, or headache may become more likely. The treatment plan should specify whether nicotine patches, gum, or lozenges are being added and for how long.
What happens if smoking continues after starting Champix?
The usual plan sets a stop-smoking date one to two weeks after treatment begins, but a person may need structured support if smoking continues. NICE guidance published in 2021 recommends behavioural support alongside pharmacological cessation treatment. Continuing to smoke does not make the tablets a nicotine product, though it can make it harder to judge progress and may preserve smoking cues.
Can Champix cause depression or suicidal thoughts?
Mood changes have been reported during smoking cessation, with and without varenicline. The FDA prescribing information (2024) requires attention to new or worsening depression, agitation, unusual behaviour, or suicidal thinking. A person who develops suicidal thoughts, severe agitation, or psychotic symptoms needs urgent medical assessment and should not remain alone.
Is Champix suitable during pregnancy?
Pregnancy requires an individual benefit–risk assessment rather than routine use. The EMA product information (2021) describes the need to weigh the benefits of stopping smoking against possible treatment risks, while WHO guidance prioritises supported tobacco cessation during pregnancy. A pregnant smoker should receive a specific treatment plan that addresses tobacco exposure, behavioural support, and medicine choice.
Does Champix interact with warfarin or insulin?
Champix itself has limited direct pharmacokinetic interaction potential, but stopping cigarette smoking can change the handling or clinical effect of several medicines. SAHPRA-aligned prescribing practice (2024) and established pharmacology references identify warfarin, theophylline, and insulin as medicines that may need monitoring when smoking stops. Patients should report their quit date so INR, blood glucose, drug levels, or symptoms can be reviewed appropriately.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Champix: Reviews and Experiences
Cravings were lower, although I struggled with insomnia. I stopped the tablets without discussing it because the sleep problem became frustrating.
The morning cigarette was the hardest habit. After about two weeks smoke-free, I still wanted one with coffee, but the urge passed faster than during earlier attempts.
The lower dose was easier to tolerate. I had some constipation and vivid dreams, but the treatment helped me stay away from cigarettes during work breaks.
I slipped during a stressful weekend. The medicine had reduced the urge, yet alcohol and familiar friends made the situation difficult. Returning to the plan worked better than giving up.
Sources
- Cochrane (2016). Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
- Journal of the American Medical Association (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders.
- European Medicines Agency (2023). Champix product information: summary of product characteristics.
- World Health Organization (2024). WHO clinical treatment guideline for tobacco cessation in adults.